First oral treatment for relapsed, refractory acute myeloid leukemia wins FDA approval

17th August 2017 Uncategorised 0

Pharmacy Times

More: First oral treatment for relapsed, refractory acute myeloid leukemia wins FDA approval
Source: MDlinx